PHARMACEUTICAL FORMULATION OF ZINC AND QUERCETINE FOR THE PRODUCTION OF ANTIVIRAL MEDICATION FOR DENGUE, ZIKA, CHIKUNGUNYA, FLU AND COLD, H1N1, N5N1, ROTAVIRUS, RHINOVIRUS AND YELLOW FEVER

摘要

Pharmaceutical Patent for compositions for the prevention or treatment of symptoms of flavivirus infections, such as dengue and zika, infections caused by h1n1, n5n1, rotavirus and chikungunya viruses. The pharmaceutical formulation comprises any substance or vehicle which provides zinc (zn ++ 2) in the body and may or may not be in combination with the flavonoid quercetin or its analogs and derivatives, including zn-quercetin chelates, and other components may enter the drug. formulation according to indication, age group, presentation form, existing pathologies and weight. The present invention is in the fields of pharmacy, notably where they may be produced for human and animal use in the following pharmaceutical forms: oral in capsules: may be hard, soft or gelatinous, tablets: may or may not be coated, dredged, filmed and dispersives, syrups, solutions, suspensions, emulsions and gel solutions. Injectables: ampoule, vial, saline and glucose. topical: ointment, cream, paste and powder. inhalation: spray and nebulizer.